Skip to main content

Table 1 Patient characteristics

From: Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study

Karnofsky performance status (median (range)) 60 (40–80)
Cancer Diagnoses  
   Prostate 11
   Colorectal 5
   Kidney 3
   Breast 3
   Pancreatic 2
   Lung 2
   Gastric 1
   Malignant melanoma 1
   Leiomyosarcoma 1
Metastases  
   Liver 7
   Bone 16
   Other 16
Antidepressants 4
Neuroleptics 1
Benzodiazepines 6
Corticosteroids 13
Antiemetics 7